Inspire Medical Systems (INSP) | Finance information

Compare Inspire Medical Systems

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Inspire Medical Systems Inc	-300.3	0%	-3%	7.1	-
Market Avg	53.2	1.27%	29%	-	1.3
Healthcare Avg	29.7	1.32%	16%	7.3	1.3

$267.50

Target Price by Analysts

72.3% upsideInspire Medical Systems Target Price Details

$231.13

Current Fair Value

48.9% upside

Undervalued by 48.9% based on the discounted cash flow analysis.

Share Statistics

Market cap	$4.72 Billion
Enterprise Value	$4.28 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-0.53
Beta	1.69
Outstanding Shares	29,711,048
Avg 30 Day Volume	785,642

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-300.3
PEG	854.74
Price to Sales	7.06
Price to Book Ratio	8.17
Enterprise Value to Revenue	6.48
Enterprise Value to EBIT	-119.02
Enterprise Value to Net Income	-273
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

ESG Score

No data

About Inspire Medical Systems Inc

CEO: Timothy Herbert

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and onl...